NutraLife’sManufacturingFacilities

By June of 2019, the Company plans to begin manufacturing at its new

20,000

Square Foot Facility

For more than five years, NutraLife’s manufacturing facility has been registered with the Food and Drug Administration (FDA) and operated in accordance with the Good Manufacturing Processes Standard (GMP). The Company’s products adhere to GMP manufacturing standards throughout every step of the manufacturing and extraction processes. NutraLife’s research, development and product testing is conducted by its in-house chemists and research staff under the director of Edgar Ward, the Company’s Chief Executive Officer, President and Director. Mr. Ward and the Company’s in-house chemists use scientific research and references to develop its product lines.

The Company’s operations are conducted at its 6,500 square foot facility in Broward County Florida. By June of 2019, the Company plans to begin manufacturing at its new 20,000 square foot facility to meet the increased demand for its products.

NutraLife uses high quality ingredients in all of its products that are supported with a certificate of analysis. In 2017, the Company launched manufacturing of its private label and branded CBD products. By the end of 2018, approximately $2,432,794 (78%) of the Company’s revenue was from its CBD products.

78% Of NutraLife’s Revenue

By the end of 2018, approximately $2,432,794 of the Company’s revenue

was from its CBD products

High Quality Ingredients

NutraLife uses high quality ingredients in all of its products that are supported with a certificate of analysis.